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KEYWORDS	
	 The	phytochemical	investigation	of	the	ethanolic	extract	of	the	aerial	parts	of	Melilotus	indicusresulted	 in	 the	 isolation	 of	 eight	 known	 flavonoids,	 namely;	 catechin	 (1),	 epicatechin	 (2),
taxifolin	 (3),	 quercetin	 (4),	 quercetin	 3‐O‐β‐D‐glucopyranoside	 (5),	 and	 quercetin	 3‐O‐α‐L‐
rhamnopyranoside	 (6),	 isorhamnetin	 3‐O‐β‐D‐glucopyranoside	 (7)	 and	 isorhamnetin	 3‐O‐β‐
D‐rutinoside	(8).	These	compounds	have	never	been	isolated	from	this	species.	The	cytotoxic
activities	of	 the	extracts	of	Melilotus	 indicus	was	evaluated	by	MTT	assay	against	 six	 cancer
cell	 lines	 using	 doxorubicin	 as	 standard	 drug.	 The	 chloroform	 extract	was	 the	most	 potent
cytotoxic	agent	against	HepG‐2cells	with	an	IC50:	9.21	µg/mL.	
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1.	Introduction	
	
The	 family	 leguminosae	 is	 one	 of	 the	 largest	 families	 of	
flowering	 plants,	 consisting	 of	 about	 463	 genera	 and	 18000	
species	 [1].	 Melilotus	is	 a	 genus	 of	 plants	 including	 20‐25	
species	that	are	widely	distributed	all	over	the	world.	Melilotus	
indicus	 (M.	 indicus)	 belongs	 to	 the	 family	 Leguminosae	 (Faba‐
ceae).	 It	 is	 an	 annual	 or	 biennial	 herb	 from	 10	 to	 50	 cm	 in	
height	 (rarely	 to	 one	 metre),	 with	 yellow	 flowers	 native	 to	
northern	 Africa,	 Europe	 and	 Asia,	 but	 naturalized	 throughout	
the	rest	of	the	world	[2].	
Flavonoids	have	received	an	increasing	attention	in	the	last	
decade,	especially	 for	 their	potential	protective	effects	against	
degenerative	 diseases	 linked	 to	 oxidative	 stress	 [3‐6].	
Chemoprevention	is	a	rapidly	growing	practical	approach	that	
focuses	 on	 cancer	 prevention	by	 the	 administration	 of	 one	 or	
more	 synthetic	 or	 naturally	 occurring	 agents	 to	 suppress	 or	
reverse	 the	 process	 of	 carcinogenesis.	 It	 is	 becoming	 increa‐
singly	 clear	 that	 chemopreventive	 compounds	 present	 in	 diet	
offer	great	potential	in	the	fight	against	cancer	by	inhibiting	the	
process	 of	 carcinogenesis	 through	 regulation	 of	 cell‐defensive	
and	 cell	 death	 machineries	 [7].	 Dietary	 chemopreventive	
substances	 are	 regarded	 as	 being	 generally	 safe,	 inexpensive	
and	 they	 have	 been	 found	 to	 contain	 various	 phytochemicals	
which	are	antioxidant	in	nature	[7].	In	Egypt,	the	leaf	extract	of	
M.	 indicus	have	been	utilized	as	food	additives	for	 the	preven‐
tion	of	many	chronic	diseases.	The	Melilotus	species	have	been	
found	 to	 contain	 coumarins	 (Coumarin,	 dihydrocoumarin	 and	
coumarol),	 acids	 (o‐Hydroxycinnamic,	 melilotic,	 coumarinic	
and	 o‐coumaric),	 coumarin	 glycosides,	 fatty	 acids	 (Linoleic	
acid)	 and	 flavonoids	 (Quercetin	 and	 coumestrol),	 triterpenes	
(Melilotoside	 A2	 and	 adzukisaponin	 V)	 as	well	 as	 xylan	 [8,9].	
Some	 of	 Melilotus	 species	 have	 been	 found	 to	 possess	 anti‐
oxidant	 and	 antibacterial	 properties	 [10,11].	 The	 aim	 of	 the	
work	described	herein	was	to	isolate	and	identify	the	flavonoid	
constituents	of	M.	indicus,	and	to	evaluate	the	cytotoxicity	of	its	
extracts.		
	
2.	Experimental	
	
2.1.	Instrumentation	
	
1H	 and	 13C	 NMR	 spectra	 were	 registered	 in	 a	 Bruker	
Advance	DRX‐400	 apparatus.	 Chemical	 shifts	 (δ)	 are	 reported	
in	 ppm	 and	 coupling	 constants	 (J)	 are	 reported	 in	 Hz.	 Mass	
spectra	 were	 registered	 in	 a	 Finnigan	 MAT90	 spectrometer	
operating	 with	 ionization	 energy	 of	 159	 eV,	 at	 positive	 and	
negative	modes.	 IR	and	UV‐Vis	 spectra	were	 registered	 in	 the	
spectrophotometers	 Shimadzu	 IR‐408,	 in	 KBr	 discs,	 and	
Shimadzu	 UV‐160A,	 respectively.	 Melting	 points	 were	 deter‐
mined	in	a	MQAPF‐301	apparatus.	
	
	
	
504	 Ahmed	and	Al‐Refai	/	European	Journal	of	Chemistry	5	(3)	(2014)	503‐506	
	
	
		
Figure	1.	Structures	of	the	isolated	flavonoids.
	
	
2.2.	Plant	material	
	
The	 aerial	 parts	 of	 M.	 indicus	 were	 collected	 from	 the	
Eastern	 Nile	 region,	 Beni‐Suef	 city	 on	 March	 2013.	 Identifi‐
cation	of	 the	plant	was	confirmed	by	the	Department	of	Flora,	
Agricultural	Museum,	Ministry	of	Agriculture	and	Herbarium	of	
the	Department	of	Botany,	Faculty	of	Science,	Cairo	University.	
Voucher	 specimen	was	 kept	 in	Herbarium,	National	 Research	
Center,	Giza,	Egypt.	
	
2.3.	Extraction	and	isolation	
	
The	air	dried	and	powdered	aerial	parts	of	M.	 indicus	 (1.8	
kg)	 were	macerated	 in	 ethanolic	 solution	 (70%).	 The	 solvent	
was	 removed	 under	 reduced	 pressure,	 and	 the	 residue	 was	
dissolved	 in	 hot	 water	 and	 extracted	 with	 chloroform,	 ethyl	
acetate	and,	n‐butanol,	successively.	The	n‐butanol	extract	(47	
g),	 a	 dark	 brown	 gum,	 was	 subjected	 to	 vacuum	 liquid	
chromatography	 (VLC)	 on	 silica	 gel	 using	 a	 gradient	 elution	
system	of	n‐hexane:EtOAc	(10:0,	9:1,	8:2,	7:3,	6:4,	5:5,	4:6,	3:7,	
2:8,	1:9	and	0:10;	v:v).	Twenty‐five	fractions	were	obtained	and	
spotted	 on	 TLC	 using	 the	 same	 solvent	 system.	 Similar	 TLC	
profiles	were	grouped	to	yield	8	fractions	(S1‐S8).	Fraction	S3	
was	 chromatographed	 on	 a	 polyamide	 column	 eluted	 with	
water	 followed	 by	 water/methanol	 solutions	 with	 increasing	
contents	 of	 methanol	 (20‐70%)	 and	 finishing	 with	 methanol.	
The	 collected	 fractions	 (217,	 25	 mL	 each)	 were	 combined	
according	 to	 their	TLC	analysis.	Fractions	14‐17	(1.3	g;	eluted	
with	water:methanol	(4:1,	v:v)	were	dissolved	in	methanol	and	
subjected	 to	 a	 sephadex	 LH‐20	 column	 and	 eluted	 with	
methanol	 for	 further	 purification	 to	 afford	 compounds	1	 (43	
mg)	and	2	(36	mg).	Compound	4	(28	mg)	was	purified	from	S5	
on	 a	 silica	 gel	 column	 using	 a	 mobile	 phase	 of	 hexane:ethyl	
acetate	(1:1,	v:v).	The	fraction	S6	was	chromatographed	over	a	
silica	 gel	 column	with	 CHCl3:MeOH	 (30:1,	 v:v)	 as	 an	 eluent	 to	
give	 seven	 sub‐fractions	 (S11‐S17).	 The	 sub‐fraction	 S13	 was	
subjected	to	a	Sephadex	LH‐20	(methylene	chloride:MeOH,	1:1,	
v:v)	and	purified	with	silica	gel	prep.	HPLC	(Econosil®	RP‐18,	
10	μ	column,	250	×	22	mm,	47%	MeOH)	to	yield	compounds	3	
(39	mg).	The	sub‐fractions	S15	and	S16	was	also	subjected	to	a	
Sephadex	 LH‐20	 (methylene	 chloride:MeOH,	 1:1,	 v:v)	 and	
purified	with	 silica	 gel	 prep.	 HPLC	 (Apollo	 Silica	 5	 μ	 column,	
250	 ×	 22	 mm;	 n‐hexane:CHCl3:EtOAc,	 7:3:1,	 v:v:v)	 to	 yield	
compounds	5	(22	mg)	and	6	(31	mg).	Fraction	S8	were	further	
TLC	 chromatographed	 on	 silica	 gel	 eluted	 with	 EtOAc:MeOH:	
H2O	 (10:1:1,	v:v:v)	 to	 obtain	 compounds	7	 (27	mg)	and	8	 (20	
mg)	(Figure	1).	
(+)‐Catechin:	 Color:	 Off‐white	 amorphous	 powder.	 M.p.:	
208‐211	°C.	 1H	NMR	(400	MHz,	CD3OD,	δ,	ppm):	2.62	(dd,	1H,					
J	=	16.1	and	8.1	Hz,	H‐4ax),	2.93	(dd,	1H,	J	=	16.1	and	5.4	Hz,	H‐
4eq),	3.98	(m,	1H,	H‐3),	4.64	(d,	1H,	J	=	7.5	Hz,	H‐2),5.87	(d,	1H,				
J	=	2.3	Hz,	H‐6),	5.94	(d,	1H,	J	=	2.3	Hz,	H‐8),	6.73	(dd,	1H,	J	=	8.1	
and	2.0	Hz,	H‐6'),	6.81	(d,	1H,	J	=	8.1	Hz,	H‐5'),	6.89	(d,	1H,	J	=	
2.0	Hz,	H‐2').	 13C	NMR	 (100	MHz,	CD3OD,	δ,	 ppm):	83.2	 (C‐2),	
69.1	(C‐3),	28.8	(C‐4),	157.9	(C‐5),	96.7	(C‐6),	158.1	(C‐7),	95.9	
(C‐8),	 157.3	 (C‐9),	 101.2	 (C‐10),	 132.5	 (C‐1'),	 115.6	 (C‐2'),	
146.3	 (C‐3'),	 146.5	 (C‐4'),	 116.5	 (C‐5'),	 120.4	 (C‐6').	 ESI‐MS	
(m/z):	291.0	[M+H]+.	[α]D	=	+	8.0	(CH3OH,	c	0.23).	
(‐)‐Epicatechin:	 Color:	 Colorless	 amorphous	 powder.	 M.p.:	
175‐176	°C.	 1H	NMR	(400	MHz,	CD3OD,	δ,	ppm):	2.74	(dd,	1H,				
J	=	16.8	and	2.9	Hz,	H‐4ax),	2.86	(dd,	1H,	J	=	16.8	and	4.3	Hz,	H‐
4eq),	4.19	(br.	s,	1H,	H‐3),	4.80	(br.	s,	1H,	H‐2),	5.92	(d,	1H,	J	=	
2.3	Hz,	H‐8),	5.95	(d,	1H,	J	=	2.3	Hz,	H‐6),	6.76	(d,	1H,	J	=	8.2,	H‐
5'),	6.80	(dd,	1H,	J	=	8.2	and	1.8	Hz,	H‐6'),	6.98	(d,	1H,	J	=	1.8	Hz,	
H‐2').	13C	NMR	(100	MHz,	CD3OD,	δ,	ppm):	80.0	(C‐2),	67.6	(C‐
3),	 29.4	 (C‐4),	 157.8	 (C‐5),	 96.6	 (C‐6),	 158.1	 (C‐7),	 96.1	 (C‐8),	
157.5	 (C‐9),	100.3	 (C‐10),	132.5	 (C‐1'),	115.5	 (C‐2'),	146.1	 (C‐
3'),	145.9	(C‐4'),	116.1	(C‐5'),	119.6	(C‐6').	ESI‐MS	(m/z):	291.0	
[M+H]+.	[α]D=	‐29.6	(CH3OH,	c	0.23).	
Taxifolin:	Color:	Yellow	crystals.	M.p.:	242	°C.	1H	NMR	(600	
MHz,	CD3OD,	δ,	ppm):	4.50	(d,	1H,	J	=	11.0	Hz,	H‐3),	4.92	(d,	1H,	
J	=	11.0	Hz,	H‐2),	5.89	(d,	1H,	J	=	2.0	Hz,	H‐8),	5.91	(d,	1H,	J	=	2.0	
Hz,	H‐6),6.81	(d,	1H,	J	=	8.0	Hz,	H‐5’),	6.86	(dd,	1H,	J	=	2.0	and	
8.0	Hz,	H‐6’),	6.97	(d,	1H,	J	=	2.0	Hz,	H‐2’).	13C	NMR	(100	MHz,	
CD3OD,	δ,	ppm):	85.1	(C‐2),	73.6	(C‐3),	198.4	(C‐4),	164.3	(C‐5),	
97.3	 (C‐6),	 168.7	 (C‐7),	 96.3	 (C‐8),	 164.5	 (C‐9),	 101.8	 (C‐10),	
129.8	 (C‐1'),	 115.9	 (C‐2'),	 116.1	 (C‐5'),	 147.1	 (C‐4'),	 146.3	 (C‐
3'),	 120.9	 (C‐6').	 FAB‐MS	 (m/z):	 305	 [M+H]+.	 [α]D=	 +	 17.6	
(CH3OH,	c	1.0).	
Quercetin:	Color:	Yellow	amorphous	powder.	M.p.:311‐317	
°C.	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	6.20	(d,	1H,	J	=	1.8	Hz,	
H‐6),	6.42	(d,	1H,	J	=	1.8	Hz,	H‐8),	6.90	(d,	1H,	J	=	8.4	Hz,	H‐5'),	
7.57	(d,	1H,	J	=	2.1	Hz,	and	8.4	Hz,	H‐6'),	7.69	(d,	1H,	J	=	2.1	Hz,	
H‐2'),	9.33	(s,	2H,	OH‐3',4'),	9.56	(s,	1H,	OH‐3),	10.77	(s,	1H,	OH‐
7),	12.50	(s,	1H,	OH‐5).	13C	NMR	(100	MHz,	DMSO‐d6,	δ,	ppm):	
147.5	 (C‐2),	 136.4(C‐3),	 176.6	 (C‐4),	 161.4(C‐5),	 98.9	 (C‐6),	
164.6	(C‐7),	94.1	(C‐8),	156.8	(C‐9),	103.7	(C‐10),	122.7	(C‐1'),	
116.3	 (C‐2'),	 145.8	 (C‐3'),	 148.4	 (C‐4'),	 115.8	 (C‐5'),	 120.7	 (C‐
6').	ESI‐MS	(m/z):	301.2	[M‐H]−.	
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Table	1.	Cytotoxicity	(IC50	in	μg/mL)of	the	extracts	of	M.	indicus	a. 
Extract	 	 IC50	(μg/mL)	
MCF‐7	 Hep‐2 HepG‐2 HeLa HCT‐116	 Caco‐2
Chloroform	extract	 22.52±1.32	 25.47±2.1 9.21±0.92 15.52±1.597 11.24±1.44	 13.83±1.71
Ethylacetate	extract	 42.53±0.47	 17.44±1.20 34.81±3.88 41.898±2.860 21.58±1.83	 26.14±1.56
Methanolic	extract	 25.65±1.90	 10.86±1.15 18.79±1.55 25.41±0.88 19.36±1.96	 29.14±1.10
Doxorubicin	(µM)	 0.48±0.04	 0.41±0.09 0.67±0.07 1.84±0.19 1.32±0.11	 0.32±0.03
a	The	data	shown	are	mean±SD	obtained	from	three	independent	experiments.	
	
	
Quercetin	 3‐O‐β‐D‐glucopyranoside:	 Color:	 Yellow	 amor‐
phous	powder.	M.p.:	224‐226	°C.	1H	NMR	(400	MHz,	DMSO‐d6,	
δ,	ppm):	3.28‐3.65	(m,	10H,	Glc),	5.37	(d,	1H,	J	=	7.63	Hz,	H‐1''),	
6.20	(d,	1H,	J	=	1.8	Hz,	H‐6),	6.40	(d,	1H,	J	=	1.8	Hz,	H‐8),	6.82	(d,	
1H,	J	=	8.62	Hz,	H‐5'),	7.53	(d,1H,	 J	=	2.12	Hz,	H‐2'	),	7.67	(dd,	
1H,	J	=	2.12	and	J	=	8.62	Hz,	H‐6'	),	9.14	(s,	1H,	OH‐4'),	9.65	(s,	
1H,	OH‐3'),	 10.81	 (s,	 1H,	OH‐7),	 12.60	 (s,	 1H,	OH‐5).	 13C	NMR	
(100	MHz,	DMSO‐d6,	δ,	ppm):	156.8	(C‐2),	133.6	(C‐3),	177.5	(C‐
4),	161.6	(C‐5),	98.9	(C‐6),	164.6	(C‐7),	93.8	(C‐8),	156.6	(C‐9),	
104.0	(C‐10),	121.6	(C‐1'),	115.8	(C‐2'),	145.8	(C‐3'),	148.8	(C‐
4'),	116.2	(C‐5'),	122.0	(C‐6'),	101.2	(C‐1''),	71.6	(C‐2''),	74.4	(C‐
3''),	 70.0	 (C‐4''),	 77.7	 (C‐5''),	 61.5	 (C‐6'').	 EI‐MS	 (m/z):	 462.9	
[M‐H]‐.	
Quercetin	 3‐O‐α‐L‐rhamnopyranoside:	 Color:	 Yellow	 amor‐
phous	powder.	M.p.:174‐179	°C.	 1H	NMR	(400	MHz,	CD3OD,	δ,	
ppm):	 1.03	 (d,	 3H,	 J	 =	 6.15	 Hz,	 CH3	 Rha),	 3.16‐3.94	 (m,	 4H,	
Rha),5.29	(d,	1H,	J	=	1.41	Hz,	H‐1''),	6.23	(d,	1H,	J	=	2.0	Hz,	H‐6),	
6.42	(d,	1H,	 J	=	2.0	Hz,	H‐8),6.90	(d,	1H,	 J	=	8.5	Hz,	H‐5'),	7.28	
(dd,	1H,	J	=	2.0	and	J	=	8.5	Hz,	H‐6'),	7.33	(d,	1H,	J	=	2.0	Hz,	H‐2').	
13C	NMR	(100	MHz,	DMSO‐d6,	δ,	ppm):	157.34	(C‐2),	134.27(C‐
3),	177.79(C‐4),	161.35	(C‐5),	98.78	(C‐6),	164.34	(C‐7),	93.70	
(C‐8),	 156.86(C‐9),	 104.16(C‐10),	 121.17	 (C‐1'),	 115.52	 (C‐2'),	
145.25	 (C‐3'),	 148.50	 (C‐4'),	 115.72	 (C‐5'),	 120.80	 (C‐6'),	
101.87	 (C‐1''),	 70.43	 (C‐2''),	 70.63	 (C‐3''),	 71.25	 (C‐4''),	 70.11	
(C‐5''),	17.54	(C‐6'').	ESI‐MS	(m/z):	447.1[M‐H]‐.	
Isorhamnetin	 3‐O‐β‐D‐glucopyranoside;	 5,7‐dihydroxy‐2‐(4‐
hydroxy‐3‐methoxy‐phenyl)‐3‐(3,4,5‐trihydroxy‐6‐hydroxy	
methyl‐tetrahydro‐pyrane‐2‐yloxy)‐chromen‐4‐one:	 Color:	
Yellow	 amorphous	 powder.	 M.p.:	 267‐269	 °C.	 1H	 NMR	 (400	
MHz,	CD3OD,	δ,	ppm):	3.07‐3.83	(m,	6H,	Glc),	3.90	(s,	3H,	OCH3‐
3'),	5.40	(d,	1H,	 J	=	8.5	Hz,	H‐1''),	6.20	(d,	1H,	J	=	2.0	Hz,	H‐6),	
6.39	(d,	1H,	J	=	1.8	Hz,	H‐8),	7.05	(d,	1H,	J	=	8.4	Hz,	H‐5'),	7.57	
(d,	1H,	J	=	2.0	Hz,	H‐2'),	7.69	(dd,	1H,	J	=	1.8	and	8.4	Hz,	H‐6').	
13C	NMR	(100	MHz,	DMSO‐d6,	δ,	ppm):	156.2	(C‐2),	133.0	(C‐3),	
177.5	 (C‐4),	 161.1	 (C‐5),	 98.8	 (C‐6),	 164.0	 (C‐7),	 93.8	 (C‐8),	
156.4	 (C‐9),	104.2	 (C‐10),	121.7	 (C‐1'),	 111.5	 (C‐2'),	149.9	 (C‐
3'),	 146.4	 (C‐4'),	 115.6	 (C‐5'),	 122.3	 (C‐6'),	 55.7	 (OCH3‐3'),	
101.0	(C‐1''),	74.2	(C‐2''),	77.2	(C‐3''),	70.0	(C‐4''),	76.6	(C‐5''),	
61.2	(C‐6'').	ESI‐MS	(m/z):	479	[M+H]+.	
Isorhamnetin	 3‐O‐β‐D‐rutinoside;	 5,7‐dihydroxy‐2‐(4‐
hydroxy‐3‐methoxy‐phenyl)‐3‐[3,4,5‐trihydroxy‐6‐(3,4,5‐tri	
hydroxy‐6‐methyl‐tetrahydropyran‐2‐yloxymethyl)‐tetrahydro‐
pyran‐2‐yloxy]‐chromen‐4‐one:	 Color:	 Yellow	 amorphous	
powder.	 M.p.:	 186‐187	 °C.	 1H	 NMR	 (400	 MHz,	 DMSO‐d6,	 δ,	
ppm):	0.98	(d,	1H,	J	=	5.6	Hz,	Rha‐H‐6),	3.07‐3.40	(m,	16H,	Rut‐
H),	3.83	(s,	3H,	OCH3‐3'),	4.41	(d,	1H,	J	=	10.8	Hz,	Rha‐H‐1),5.44	
(d,	1H,	J	=	7.3	Hz,	Glc‐H‐1),	6.19	(d,	1H,	J	=	1.9	Hz,	H‐6),	6.41	(d,	
1H,	J	=	1.8	Hz,	H‐8),	6.92	(d,	1H,	J	=	8.4	Hz,	H‐5'),	7.53	(dd,	1H,	J	
=	2.0,	8.4	Hz,	H‐6'),	7.86	(d,	1H,	J	=	2.0	Hz,	H‐2'),	9.83	(s,	1H,	OH‐
4'),	10.89	(s,	1H,	OH‐7),	12.50	(s,	1H,	OH‐5).	13C	NMR	(100	MHz,	
DMSO‐d6,	δ,	ppm):	156.7	(C‐2),	133.2	(C‐3),	177.4	(C‐4),	161.4	
(C‐5),	99.1	(C‐6),	165.0	(C‐7),	94.1	(C‐8),	156.5	(C‐9),	103.9	(C‐
10),	 121.2	 (C‐1'),	 113.5	 (C‐2'),	 149.6	 (C‐3'),	 55.9	 (OCH3‐3'),	
147.1	 (C‐4'),	 115.5	 (C‐5'),	 122.5	 (C‐6'),	 101.5	 (glc‐C‐1),	 74.5	
(glc‐C‐2),	76.6	(glc‐C‐3),	70.8	(glc‐C‐4),	76.1	(glc‐C‐5),	67.0	(glc‐
C‐6),	101.1	(rha‐C‐1),	70.5	(rha‐C‐2),	70.8	(rha‐C‐3),	72.0	(rha‐
C‐4),	68.5	(rha‐C‐5),	17.8	 (rha‐C‐6).	ESI‐MS	(m/z):	623	[M‐H]‐,	
647	[M+Na]+.	
	
	
	
2.4.	Cell	culture	
	
MCF‐7	 (breast	 adenocarcinoma),	 Hep‐2	 (human	 epithelial	
laryngeal	carcinoma),	HepG‐2	(hepatocellular	carcinoma),	HeLa	
(human	 cervix	 adenocarcinoma),	 HCT‐116	 (colorectal	 adeno‐
carcinoma)	 and	 Caco‐2	 (colon	 adenocarcinoma)	 cells	 were	
obtained	from	American	Type	Culture	Collection	(ATCC).	HeLa	
and	Hep‐2	cells	were	cultured	in	Dulbecco's	modified	essential	
medium,	and	 the	other	cells	were	maintained	 in	a	RPMI‐1640	
medium	in	a	humidified	5%	CO2	atmosphere	at	37	°C.	All	media	
were	 supplemented	with	penicillin	 (100	U/mL),	 streptomycin	
(100	 μg/mL)	 and	 10%	 heat‐inactivated	 fetal	 bovine	 serum	
(FBS).	
	
2.5.	Cytotoxicity	assay	
	
Cytotoxic	activities	were	measured	 in‐vitro	 the	human	cell	
lines	 with	 the	 MTT	 (3‐(4,5‐dimethylthiazol‐2‐yl)2,5‐diphenyl	
tetrazolium	 bromide)	 assay	 [12].	 Briefly,	 a	 limited	 number	 of	
human	 cancer	 cells	 (5000/well)	 were	 seeded	 onto	 a	 96‐well	
microplate	 and	 became	 attached	 to	 the	 bottom	 of	 the	 well	
overnight.	 On	 the	 second	 day	 of	 the	 procedure,	 the	 original	
medium	was	removed	and	200	μL	new	medium	containing	the	
tested	extracts	was	added.	After	an	 incubation	period	of	24	h,	
the	living	cells	were	assayed	by	the	addition	of	20	μL	5	mg/mL	
MTT	 solution.	 MTT	 was	 converted	 by	 intact	 mitochondrial	
reductase	and	precipitated	as	blue	crystals	during	a	4	h	contact	
period.	 The	 medium	 was	 then	 removed	 and	 the	 precipitated	
crystals	were	dissolved	in	100	μL	DMSO	during	a	60	min	period	
of	 shaking.	 Finally,	 the	 reduced	MTT	was	 assayed	 at	 545	 nm	
using	 a	 microplate	 reader,	 wells	 with	 untreated	 cells	 being	
taken	 as	 the	 control.	 All	 invitro	 experiments	were	 carried	 out	
on	two	microplates	with	at	least	five	parallel	wells.	Doxorubicin	
was	used	as	a	positive	control.	Stock	solutions	of	10	mg/mL	of	
the	 tested	 extracts	 were	 prepared	 with	 dimethyl	 sulphoxide	
(DMSO).	 The	 highest	 DMSO	 concentration	 (0.3%)	 of	 the	
medium	did	not	have	any	significant	effect	on	cell	proliferation.	
The	 dose‐response	 curves	 of	 the	 compounds	 were	 fitted	 by	
means	 of	 the	 computer	 program	 GraphPad	 Prism	 4.0	 (Graph	
Pad	 Software,	 San	 Diego,	 CA,	 USA),	 and	 IC50	 values	 were	
calculated.	
	
3.	Results	and	discussion		
	
The	 ethanolic	 extract	 of	 M.	 indicuswas	 fractionated	 and	
purified	by	various	 chromatographic	 techniques.	 Eight	 known	
flavonoids	 (1‐8)	 were	 isolated	 for	 the	 first	 time	 from	 this	
species	 (Figure	 1).	 The	 structural	 elucidation	 of	 the	 isolated	
flavonoids	 was	 achieved	 through	 chemical	 and	 spectroscopic	
analysis,	 including	 HRMS,	 UV,	 1H,	 13C	 and	 2D	 NMR,	 and	 by	
comparison	with	 reported	 data.	 The	 isolated	 flavonoids	were	
identified	 as	 catechin	 (1)	 [13,14],	 epicatechin	 (2)	 [15,16],	
taxifolin	 (3)	 [17,18],	 quercetin	 (4)	 [19‐21],quercetin	 3‐O‐β‐D‐
glucopyranoside	 (5)	 [21‐23],	 and	 quercetin	 3‐O‐α‐L‐
rhamnopyranoside	 (6)	 [21,24‐26],	 isorhamnetin	 3‐O‐β‐D‐
glucopyranoside	 (7)	 [21,27‐29]	 and	 isorhamentin	 3‐O‐β‐D‐
rutinoside	(8)	[21,25,30].	
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The	anti‐proliferative	activity	of	 three	extracts	 from	aerial	
parts	ofM.	indicuswas	determined	against	Hep‐2,	HepG‐2,	HeLa,	
HCT‐116	and	Caco‐2	cells	by	MTT	assay	using	doxorubicin	as	a	
positive	control.	The	IC50	values	are	presented	in	Table	1.		
Phytochemicals	 have	 been	 shown	 to	 be	 effective	 in	
preventing	 malignant	 transformation	 of	 cells	 in	 culture	 and	
experimentally	 induced	 tumorigenesis	 in	 various	 animal	
models.	Mechanistically,	chemoprevention	with	dietary	phyto‐
chemicals	 could	 be	 achieved	 by	 stimulating	 inactivation	 of	
potential	carcinogens,	inhibition	of	abnormal	cell	proliferation,	
induction	 of	 apoptosis	 and	 delaying	 angiogenesis	 [31].	 The	
present	study	was	undertaken	to	investigate	the	potential	of	M.	
indicus	 chloroform,	 ethyl	 acetate	 and	 methanol	 extract	 as	 a	
chemopreventive	 agent	 by	 evaluating	 its	 effect	 on	 viable	 cell	
number	and	by	evaluating	the	sensitivity	of	different	cancer	cell	
lines	 to	 the	 extract.	 The	 results	 of	 the	present	 study	demons‐
trated	that,	the	cytotoxicity	of	chloroform	extracts	was	superior	
to	that	of	the	methanol	and	water	extracts,	it	exhibited	a	dose‐
dependent	growth	inhibitory	effect	after	a	continuous	exposure	
during	a	24	h	period.	The	cytotoxic	effect	was	greater	on	HepG‐
2	 and	 HCT‐116	 cell	 lines.	 The	 most	 effective	 cytotoxic	 agent	
was	the	chloroform	extract	against	HepG‐2,	HCT‐116,	HeLa	and	
Caco‐2	 cells	with	 an	 IC50	 9.21,	11.24,	15.52	 and	13.83	μg/mL,	
respectively.	 In	 contrast,	 the	 most	 potent	 cytotoxic	 agent	
against	 Hep‐2	 cells	 was	 the	 methanolic	 extract	 with	 an	 IC50	
10.86	μg/mL.	
	
4.	Conclusion	
	
Four	flavonoid	aglycons	and	four	flavonoid	glycosides	were	
isolated	 from	 ethanolic	 extract	 of	 Melilotusindicus.	 Their	
structures	 were	 confirmed	 by	 comparison	 of	 their	 chromato‐
graphic	 properties,	 chemical	 and	 spectroscopic	 data	 (UV,	 1H	
and	 13C	 NMR)	 with	 those	 reported	 in	 the	 literature.	 The	
antiproliferative	 assay	 of	 chloroform,	 ethyl	 acetate	 and	
methanol	 extract	 have	 been	 evaluated	 by	 MTT	 assay	 using	
doxorubicin	 as	 a	 positive	 control,	 and	 it	 has	 been	 shown	 that	
the	 methanol	 extract	 was	 the	 most	 potent	 antitumor	 agent	
against	Hep‐2	cell	line.	
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